Achelios Therapeutics, Inc. — Form D
Achelios Therapeutics, Inc. of CHAPEL HILL, NC, a company, filed a Form D exempt-offering notice with the SEC on 2016-04-19. The offering totals $2.0M, of which $350K was reported sold. Industry: Other Health Care.
Offering
- Filed: 2016-04-19
- Form: D
- Accession: 0001542874-16-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $350K
- Remaining: $1.6M
- Investors: 2
- Date of first sale: 2016-04-07
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-261596
Issuer
- Name: Achelios Therapeutics, Inc.
- CIK: 0001542874
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 6340 QUADRANGLE DRIVE, CHAPEL HILL, NC, 27517
- Phone: 919-354-6233
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Crist J Frangakis | Director | Chapel Hill, NC |
| Jerry J Rosenblatt | Director | Mont-Royal, A8 |
| Ron J Vered | Director | Ottowa, A6 |
| Crist J Frangakis | Executive Officer | Chapel Hill, NC |
| William J Dickie | Director | Chapel Hill, NC |
| William J Bauer | Director | Chapel Hill, NC |
| Crist Frangakis | Executive Officer | Chapel Hill, NC |
Other filings by this issuer (2)
More